Pediatric Nephrology

, Volume 2, Issue 4, pp 447–452 | Cite as

Hyperlipidemia in pediatric patients undergoing peritoneal dialysis

  • U. Querfeld
  • I. B. Salusky
  • P. Nelson
  • J. Foley
  • R. N. Fine
Original Article


We evaluated serial measurements of serum lipid levels in 68 patients aged 12.6±4.7 years undergoing treatment with continuous ambulatory peritoneal dialysis/continuous cycling peritoneal dialysis (CAPD/CCPD). Fasting mean levels of triglycerides (TG) and cholesterol (C) were elevated above the 95th percentile of published normal values by 102% and 19%, respectively, at the start of dialysis. Except for a shortterm decrease in TG levels at 6 and 9 months, no significant change in mean lipid levels was observed during a follow-up period of 2 years. At initiation of dialysis, elevated TG and C levels were present in 90% and 69% of the patients, respectively. The prevalence of hyperlipidemia (HL) varied between 63% and 88% (TG) and 61% and 93% (C), respectively, during the follow-up period. TG and C levels were not correlated with caloric intake (evaluated in 17 patients), serum albumin levels, treatment modality (CAPD or CCPD), a history of the nephrotic syndrome, or previous treatment with hemodialysis or transplantation. However, a significant inverse correlation was observed between age and serum lipids at the initiation of dialysis treatment and after 1 year (TG:r=−0.40; C:r=−0.44). Our data indicate a high prevalence of HL but no significant change of serum lipid levels during 2 years of treatment with CAPD/CCPD.

Key words

Hyperlipidemia Triglycerides Cholesterol Peritoneal dialysis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bagdade JD (1978) Hyperlipidemia and atherosclerosis in chronic dialysis patients. In: Drukker W, Parsons FM, Maher JF (eds) Replacement of renal function by dialysis. Martinus Nijhoff, Amsterdam, pp 538–545Google Scholar
  2. 2.
    Pennisi AJ, Heuser ET, Mickey MR, Lipsey A, Malekzadeh MH, Fine RN (1976) Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Am J Dis Child 130:957–961Google Scholar
  3. 3.
    Keusch G, Bammatter F, Mordasini R, Binswanger U (1981) Serum lipoprotein concentrations during continous ambulatory peritoneal dialysis. In: Gahl GM, Kessel M, Nolph KD (eds) Advances in peritoneal dialysis. Excepta Medica, Amsterdam, pp 427–429Google Scholar
  4. 4.
    Ramos JM, Heaton A, McGurk JG, Ward MK, Kerr DNS (1983) Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis. Nephron 35:20–23Google Scholar
  5. 5.
    Lindholm B, Bergstroem J, Norbeck HE (1981) Lipoprotein metabolism in patients on continuous ambulatory peritoneal dialysis. In: Gahl GM, Kessel M, Nolph KD (eds) Advances in peritoneal dialysis. Excerpta Medica, Amsterdam, pp 434–436Google Scholar
  6. 6.
    Christensen B, Glueck C, Kwiterovich P, Degroot I, Chase G, Heiss G, Movery R, Tamir I, Rifkind B (1979) Plasma cholesterol and triglyceride distributions in 13,665 children and adolescent: the prevalence study of the Lipid Research Clinics program. Pediatr Res 14:194–202Google Scholar
  7. 7.
    The Lipid Research Clinics Program Epidemiology Committee (1979) Plasma lipid distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study. Circulation 60:427–439Google Scholar
  8. 8.
    The Committee on Dietary Allowances (1980), Recommended dietary allowances. National Academy of Sciences, Washington D. C., p 16Google Scholar
  9. 9.
    Salusky IB, Fine RN, Nelson P, Blumenkrantz MJ, Kopple JD (1983) Nutritional status of children undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr 38:599–611Google Scholar
  10. 10.
    Heuck CC, Ritz E (1980) Hyperlipoproteinemia and renal insufficiency. Nephron 25:1–7Google Scholar
  11. 11.
    Chan MK, Varghese Z, Moorhead JF (1981) Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int 19:625–637Google Scholar
  12. 12.
    Report of the Southwest Pediatric Nephrology Study Group (1985) Continuous ambulatory and continuous cycling peritoneal dialysis in children. Kidney Int 27: 558–564Google Scholar
  13. 13.
    Lindholm B, Norbeck HE (1986) Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis. Acta Med Scand 220:143–151Google Scholar
  14. 14.
    Broyer M, Niaudet P, Champion G, Jean G, Chopin N, Czernichow P (1983) Nutritional and metabolic studies in children on continuous ambulatory peritoneal dialysis. Kidney Int 24 [Suppl 24]: S 106–110Google Scholar
  15. 15.
    Dulaney JT, Hatch F (1984) Peritoneal dialysis and loss of proteins: a review. Kidney Int 26:253–262Google Scholar
  16. 16.
    Querfeld U, Haberbosch W, Gnasso A, Heuck CC, Augustin J (1984) Lipoprotein profiles in plasma and dialysate of children on CAPD. In: Fine RN, Schaerer K, Mehls O (eds) CAPD in Children. Springer Berlin Heidelberg New York, pp 69–78Google Scholar
  17. 17.
    Querfeld U, Salusky IB, LeBoeuf R, Montcalm A, Fine RN (1986) Lipoprotein profiles in children treated with CAPD/CCPD for more than tow years. Pediatr Nephrol 1:C 38Google Scholar
  18. 18.
    Matsuyama T, Itoh H, Hasegawa O, Honda M, Hayashi S, Nakahara C, Hasegawa A, Kawamaura T (1986) Lipoprotein and apoprotein abnormalities in children undergoing continuous ambulatory peritoneal dialysis (CAPD). Pediatr Nephrol 1:C38Google Scholar

Copyright information

© IPNA 1988

Authors and Affiliations

  • U. Querfeld
    • 1
  • I. B. Salusky
    • 1
  • P. Nelson
    • 1
  • J. Foley
    • 1
  • R. N. Fine
    • 1
  1. 1.Department of PediatricsUCLA School of Medicine, Division of Pediatric NephrologyLos AngelesUSA

Personalised recommendations